Kura Oncology's market cap is currently $727.36M. The company's EPS TTM is $-0.75; its P/E ratio is ―; Kura Oncology is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
